Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sensitivity of screening kits for anti-HIV-1 subtype O antibodies.
Simon F, Ly TD, Baillou-Beaufils A, Fauveau V, De Saint-Martin J, Loussert-Ajaka I, Chaix ML, Saragosti S, Courouce AM, Ingrand D, et al. Simon F, et al. Among authors: chaix ml. AIDS. 1994 Nov;8(11):1628-9. doi: 10.1097/00002030-199411000-00021. AIDS. 1994. PMID: 7848605 Clinical Trial. No abstract available.
HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients.
Loussert-Ajaka I, Ly TD, Chaix ML, Ingrand D, Saragosti S, Couroucé AM, Brun-Vézinet F, Simon F. Loussert-Ajaka I, et al. Among authors: chaix ml. Lancet. 1994 Jun 4;343(8910):1393-4. doi: 10.1016/s0140-6736(94)92524-0. Lancet. 1994. PMID: 7910884
Diversity of the V3 region of HIV in Paris, France.
Chaix ML, Chappey C, Couillin I, Rozenbaum W, Levy JP, Saragosti S. Chaix ML, et al. AIDS. 1993 Sep;7(9):1199-204. doi: 10.1097/00002030-199309000-00008. AIDS. 1993. PMID: 8216976
Increase of HIV-1 subtype A in Central African Republic.
Müller-Trutwin MC, Chaix ML, Letourneur F, Bégaud E, Beaumont D, Deslandres A, You B, Morvan J, Mathiot C, Barré-Sinoussi F, Saragosti S. Müller-Trutwin MC, et al. Among authors: chaix ml. J Acquir Immune Defic Syndr. 1999 Jun 1;21(2):164-71. J Acquir Immune Defic Syndr. 1999. PMID: 10360809
Zidovudine genotypic resistance in HIV-1-infected newborns in the French perinatal cohort.
Masquelier B, Chaix ML, Burgard M, Lechenadec J, Doussin A, Simon F, Cottalorda J, Izopet J, Tamalet C, Douard D, Fleury H, Mayaux MJ, Blanche S, Rouzioux C; French Pediatric HIV Infection Study Group. Masquelier B, et al. Among authors: chaix ml. J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):99-104. doi: 10.1097/00126334-200106010-00001. J Acquir Immune Defic Syndr. 2001. PMID: 11404530
Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome.
Aboulker JP, Babiker A, Chaix ML, Compagnucci A, Darbyshire J, Debré M, Faye A, Giaquinto C, Gibb DM, Harper L, Saïdi Y, Walker AS; Paediatric European Network for Treatment of AIDS. Aboulker JP, et al. Among authors: chaix ml. AIDS. 2004 Jan 23;18(2):237-45. doi: 10.1097/00002030-200401230-00013. AIDS. 2004. PMID: 15075541 Clinical Trial.
335 results